CM CM
Company Profile ↓Company Overview
CM (CM) is a publicly traded company listed on with a market capitalization of $109.97B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 10.7% per year over the last five years.
Revenue has grown at a 10.1% CAGR over the past five years.
Trades at an undemanding P/E of 13.8.
Maintains a net profit margin of 29.0%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Oct 2025 Revenue of $29.01B (+13.7% YoY); net profit $8.43B.
- Trailing 12 Months Year-on-year growth — revenue +13.7%, earnings +18.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 10.1%, profit CAGR 10.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 10.06% |
| 1 Year: | 13.66% |
Compounded Profit Growth
| 5 Years: | 10.66% |
| 1 Year: | 18.47% |
Stock Price Performance
| 1 Year: | +66.13% |
| 6 Months: | +26.88% |
| 3 Months: | +8.50% |
| 1 Month: | +2.39% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)55.10 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 29.0%.
- Compounding revenue at 10.1% over 5 years.
- Profit CAGR of 10.7% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 6.99B | 7.22B | 7.55B | 8.32B | 7.96B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| Interest Expense | - | 8.07B | 8.04B | 7.96B | 7.49B | 7.26B |
| Pretax Income | - | 2.60B | 2.72B | 2.79B | 3.50B | 3.20B |
| Tax Provision | - | 591.00M | 623.00M | 612.00M | 401.00M | 737.00M |
| Net Income | - | 2.00B | 2.09B | 2.17B | 3.09B | 2.46B |
| Diluted EPS | 2.19 | 2.04 | 2.15 | - | 3.21 | 2.53 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Revenue | - | 21.76B | 23.30B | 25.53B | 29.01B |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 9.54B | 32.19B | 38.49B | 32.99B |
| Pretax Income | - | 7.97B | 6.97B | 9.17B | 10.94B |
| Tax Provision | - | 1.73B | 1.93B | 2.01B | 2.48B |
| Net Income | - | 6.22B | 5.00B | 7.12B | 8.43B |
| Diluted EPS | - | 6.68 | 5.17 | 7.28 | 8.57 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 943.60B | 975.69B | 1.04T | 1.12T |
| Current Assets | - | - | - | - | - |
| Cash & Equivalents | - | 73.33B | 63.17B | 56.03B | 55.75B |
| Inventory | - | - | - | - | - |
| Receivables | - | 3.28B | 4.35B | 5.45B | 5.87B |
| Total Liabilities | - | 893.22B | 922.53B | 982.98B | 1.05T |
| Current Liabilities | - | - | - | - | - |
| Long Term Debt | - | 107.25B | 116.84B | 125.10B | 140.88B |
| Total Debt | - | 187.45B | 194.50B | 208.49B | 225.78B |
| Total Equity | - | 50.18B | 52.93B | 58.73B | 64.13B |
| Shares Outstanding | - | 906.04M | 931.10M | 942.29M | 926.61M |
Cash Flows (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 22.71B | 12.15B | 11.09B | 13.84B |
| Investing Cash Flow | - | -24.39B | -20.76B | -20.75B | -5.78B |
| Financing Cash Flow | - | -1.61B | -2.16B | -2.61B | -4.31B |
| Capital Expenditure | - | -1.11B | -1.01B | -1.09B | -1.11B |
| Free Cash Flow | - | 21.61B | 11.14B | 10.00B | 12.73B |
| Net Change in Cash | - | -3.29B | -10.77B | -12.27B | 3.75B |
Ratios (Annual)
Figures in %.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 28.6% | 21.5% | 27.9% | 29.1% |
| ROE % | - | 12.4% | 9.4% | 12.1% | 13.1% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CM
CIBC (TSX:CM) Stock Could Be Undervalued Even After A 233% Run - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNWkp1a3c0OW9zWDlIdzVnQW1oRkd4Rzc4cEZjYk5xYUl4bXBIV2pwOGR3aGJTdnZaNktKWXlSMGVfRHJLWUpZVThjbUxucWRmRG5kekw4RG9mYXdINXV3UXJKMXZGRC1lZl9IbVNPRzZzanZiSnpZUk5HRnFWZ0h1TnR2WGhGM2g5LXltT0…
Canadian Imperial Bank of Commerce $CM Shares Acquired by Quantinno Capital Management LP - MarketBeat
<a href="https://news.google.com/rss/articles/CBMi4wFBVV95cUxPbU5mN1dKT1ZCMERELTJBeGc3MjE2NV94TWpPTEJXNzBYYW9nWjMydjNSY0ZMNTRlclJVNmVsMzNEYUstZmRURllvLXJ5bW1ueTZBV0dZb0QtVDItdkNKWlBuNWtLeVZQSWZEZVlxSzRpLTFmaWdmUXNpTVlOTFFNU1RPWlhDMVBleVBYS2…
Vanguard Capital Management (CM) reports 45.9M Canadian Imperial Bank of Commerce shares - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxQbmJtblRhT3ZXN0NhTDZ4Qk4teXJ6UUxPb0hvemwxVmh3bmVqbkJMOHZPblo4eUlHSkNFMU52WUdzMS1IUEV6d1MwbjhPaGg4VjBlUlo0Z1dUYVBEaWhfeDR2SDZsdDUzNUtydTdkR2RjWmh6TUR2cEZRT1lkaE1pZllYcW9tWnRjVDNwUm…
Weekly Recap: CIBC (CM) AdvisorAssist AI and LSE structured notes - TradingView
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxPRmFld2V3RVVKTng0MkhORE82bFZwS3k3b0VRejlmRVBrR3I4bDdUS2pobjRYNk1KZTFGNlp2aExLZlV2eVJRSUJaQTJkVC02V2NrZ2Y1MS14a1hnYU9Ha2dwQ09hclBSMVhKcThySGN2TXBvZ3JqWEFSdnQ3T3hkb2NFdEFwTmxYNzB4Tn…
Canadian Imperial Bank of Commerce stock rises Tuesday, still underperforms market - MarketWatch
<a href="https://news.google.com/rss/articles/CBMi2AFBVV95cUxOQ2ExQkVGWlJsb0Z6TGFFTVZYVUw1cl9Xb0o0dFIyV0plYmMtNVNzX3RIZG5ES2JMUURmcnRyX01jXzhZTGIxU2pGcUI1b3c2QlNFQU9kSm5HLXdwTU5rTGo4NlFOdVNvcmV0UlhvelphLTlRLUF4c2Q2eTRUZGtwdmNXRmdPOU93REtOcU…
AstraZeneca and Ionis’ stocks drop significantly on Wainua ATTR-CM trial failure - Clinical Trials Arena
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPUmhSbmRKVVJQbVRmMmxRd2cteDZoeHdabjEwR0FMdDVtaVVtdXdsQmlJVS1jSG1VMGFSbHBGRnBLcEpuX0lhN3ljZU9ILTZxX09KT2RyTlFKTklkWnMtX2ZiRk1ZbmxfUlN6clR6QlMyYzduandhQ09CWmtTbE52R3d0dFNnVS03YXc5bl…
CM — Frequently Asked Questions
What is the current share price of CM?
As of 2026-08-05 17:25 PDT, CM trades at $118.68 on NASDAQ/NYSE. Its 52-week range is $70.90 to $121.24.
What is the market capitalisation of CM?
CM has a market capitalisation of $109.97B on NASDAQ/NYSE.
What is the P/E ratio of CM?
CM trades at a trailing price-to-earnings (P/E) ratio of 13.85. Its price-to-book (P/B) ratio is 1.71.
What is the return on equity (ROE) of CM?
CM has a return on equity (ROE) of 13.14%.
Is CM a good stock to buy?
This page provides a data-driven analysis of CM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.